Evercore ISI Group Maintains In-Line on Zimmer Biomet Holdings, Lowers Price Target to $115
Portfolio Pulse from Benzinga Newsdesk
Evercore ISI Group analyst Vijay Kumar maintains an In-Line rating on Zimmer Biomet Holdings (NYSE:ZBH) but lowers the price target from $130 to $115.
July 02, 2024 | 3:59 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Evercore ISI Group analyst Vijay Kumar maintains an In-Line rating on Zimmer Biomet Holdings but lowers the price target from $130 to $115.
The lowered price target from $130 to $115 suggests a less optimistic outlook for Zimmer Biomet Holdings, which could negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100